OBJECTIVE: To assess the effect of endogenous estrogens on the bioavailability of nitric oxide (·NO) and in the formation of lipid peroxidation products in pre- and postmenopausal women. METHODS: NOx and S-nitrosothiols were determined by gaseous phase chemiluminescence, nitrotyrosine was determined by ELISA, COx (cholesterol oxides) by gas chromatography, and cholesteryl linoleate hydroperoxides (CE18:2-OOH), trilinolein (TG18:2-OOH), and phospholipids (PC-OOH) by HPLC in samples of plasma. RESULTS: The concentrations of NOx, nitrotyrosine, COx, CE18:2-OOH, and PC-OOH were higher in the postmenopausal period (33.8±22.3 mM; 230±130 nM; 55±19 ng/mL; 17±8.7 nM; 2775±460 nM, respectively) as compared with those in the premenopausal period (21....
Objective: To assess nitro oxidant concern in females through polycystic ovarian disorder and ongoin...
OBJECTIVE: Oestradiol (E2) and its metabolites 2-hydroxyoestrone (2-OHE1) and 16alpha-hydroxyoestron...
WOS: 000291110400005PubMed ID: 21567464Background: It has been reported that estrogen deficiency aft...
Our purpose was to assess the effects of estrogen replacement therapy on plasma levels of nitric oxi...
Objective: A number of studies have consistently shown a lower cardiovascular risk in women who rece...
Objective: To investigate the acute effects of transdermal E2 administration on nitric oxide {NO} pl...
Background: The metabolic syndrome (METS) increases after the menopause which may enhance cardiovasc...
Objective: To assess the effects of short-term transdermal E, administration on nitric oxide (NO) pl...
OBJECTIVE: Antioxidant and protective effect of high density lipoprotein (HDL) cholesterol for ather...
Objective: Our purpose was to assess the effects of transdermal estrogen replacement therapy (TERT) ...
Background: Menopause is associated with increased oxidative stress and decreased antioxidative acti...
The aim of the study was to investigate the effects of estrogen replacement therapy (ERT) on nitric ...
Background: Postmenopausal women have increased oxidative stress and decreased antioxidant status. E...
ABSTRACT Objectives: To evaluate the relation between climacteric symptoms or other risk factors for...
AbstractCardiovascular diseases (CVD) are the most significant cause of death in postmenopausal wome...
Objective: To assess nitro oxidant concern in females through polycystic ovarian disorder and ongoin...
OBJECTIVE: Oestradiol (E2) and its metabolites 2-hydroxyoestrone (2-OHE1) and 16alpha-hydroxyoestron...
WOS: 000291110400005PubMed ID: 21567464Background: It has been reported that estrogen deficiency aft...
Our purpose was to assess the effects of estrogen replacement therapy on plasma levels of nitric oxi...
Objective: A number of studies have consistently shown a lower cardiovascular risk in women who rece...
Objective: To investigate the acute effects of transdermal E2 administration on nitric oxide {NO} pl...
Background: The metabolic syndrome (METS) increases after the menopause which may enhance cardiovasc...
Objective: To assess the effects of short-term transdermal E, administration on nitric oxide (NO) pl...
OBJECTIVE: Antioxidant and protective effect of high density lipoprotein (HDL) cholesterol for ather...
Objective: Our purpose was to assess the effects of transdermal estrogen replacement therapy (TERT) ...
Background: Menopause is associated with increased oxidative stress and decreased antioxidative acti...
The aim of the study was to investigate the effects of estrogen replacement therapy (ERT) on nitric ...
Background: Postmenopausal women have increased oxidative stress and decreased antioxidant status. E...
ABSTRACT Objectives: To evaluate the relation between climacteric symptoms or other risk factors for...
AbstractCardiovascular diseases (CVD) are the most significant cause of death in postmenopausal wome...
Objective: To assess nitro oxidant concern in females through polycystic ovarian disorder and ongoin...
OBJECTIVE: Oestradiol (E2) and its metabolites 2-hydroxyoestrone (2-OHE1) and 16alpha-hydroxyoestron...
WOS: 000291110400005PubMed ID: 21567464Background: It has been reported that estrogen deficiency aft...